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Abstract
Pathogenesis of arterial hypertension is complex and in spite of the decades of studies is not yet entirely understood. 
In recent years, attention has been paid to the phenomenon of foetal programming and its relationship to arterial 
hypertension in adult life. It has been shown that low birth weight predisposes to the development of arterial hy-
pertension. The relationship between the number of nephrons and blood pressure and the risk of hypertension also 
has been found. Blood pressure and the number of nephrons depend on both genetic and environmental factors 
affecting pregnant females. The aim of this review is to summarize the current knowledge concerning the role of 
foetal programming in the pathogenesis of arterial hypertension in adults.
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Introduction
Pathogenesis of arterial hypertension is complex 
and in spite of the decades of studies is not yet entire-
ly understood. All potential risk factors contributing 
to the pathogenesis of arterial hypertension can be 
divided into three groups: genetic factors (e.g. mono-
genic forms of hypertension), congenital factors (e.g. 
low birth weight) and acquired factors (e.g. renal 
artery stenosis). According to the Barker’s hypothesis 
(i.e. foetal programming hypothesis), harmful factors 
such as limited intake of nutrients, placenta dysfunc-
tion, hyperglycaemia and cigarette smoking during 
pregnancy result in occurrence of chronic diseases 
such as arterial hypertension, ischaemic heart disease, 
chronic kidney disease and metabolic syndrome in 
adult life [1, 2]. The aim of this review is to sum-
marize the current knowledge concerning the role of 
foetal programming in the pathogenesis of arterial 
hypertension in adults.
Low birth weight
A low birth weight according to the WHO defi-
nition is the weight of live-born infants lower than 
2,500 g or below the 10th percentile for the gesta-
tional age (small for gestational age — SGA). A me-
ta-analysis of 20 clinical trials showed 21% higher 
risk of arterial hypertension in adult life in subjects 
with low birth weight compared with those with 
normal birth weight [3]. Subjects with a birth weight 
lower than 2,500 g are characterized by 2.6 mm Hg 
higher systolic blood pressure [3]. 
Kidney development, nephron number 
and blood pressure
Intrauterine growth retardation affects the kidney 
development. There is a lot of evidence that kidney 
plays a crucial role in pathogenesis of arterial hyper-
tension. Rettig et al. in experimental study trans-
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planted a kidney from a spontaneously hypertensive 
rats (SHR) to rats with normal blood pressure. After 
the transplantation normotensive rats (WKR) de-
veloped hypertension [4]. In another experimental 
study, transplantation of the kidney from normo-
tensive donor rats lead to decrease in blood pressure 
in recipient rat with hypertension [5]. In humans, 
in the 4.5-year follow-up of 6 patients with chron-
ic kidney disease due to hypertension, after kidney 
transplantation it was observed not only normaliza-
tion of blood pressure, but also partial regression of 
the hypertensive organ complications [6]. 
A number of both experimental and clinical stud-
ies suggest the relationship between low nephron 
number and arterial hypertension. In humans there is 
high variability of the number of nephrons between 
individuals. Puelles et al. in the study of 800 autop-
sies found that the number of glomeruli in human 
kidney varies between 210,000 and 2,700,000 [7]. 
Keller et al. in autopsy study compared the num-
ber of glomeruli in patients with essential hyper-
tension and those without hypertension [8]. They 
found that the number of glomeruli per kidney 
was significantly lower in hypertensive patients than 
in normotensive subjects (890,869 vs 1,666,805). 
This observation was confirmed in other study [9]. 
In humans nephrogenesis is finished in 34 weeks 
of gestational age and there is no further nephron 
number increase to the end of life [10]. Therefore, 
the number of nephrons is determined in the foetal 
period. Glomerular adaptation to the increased size 
of the body during growth in humans is through 
glomeruli hypertrophy, only. 
Factors affecting the nephron number
Manalich et al. performed an autopsy study in 
newborns. They showed that the number of glomer-
uli significantly depends on the birth weight [11]. In-
terestingly, Hughson et al. in another autopsy study 
have shown that 1-kg increase in the birth weight 
results in an increase in the number of glomeruli 
by over 250,000 [12]. Studies on white newborns 
identified some polymorphic variants of the human 
tyrosine kinase receptor gene (RET) associated with 
a reduction by 10–23% of newborn kidney volume 
[13]. It has been shown that kidney size correlates 
positively with the number of glomeruli per kidney 
[14, 15]. In Swiss Kidney Project on Genes in Hy-
pertension (SKIPOGH) observational study involv-
ing 793 subjects from 205 families it has been shown 
that the length of the kidney depends on genetic 
factors in 50% [16]. Therefore it can be assumed that 
nephron number depends on environmental factors 
in the remaining 50%.
Environmental factors
Different environmental factors may influence 
nephrogenesis and may affect the foetus’ number of 
nephrons and blood pressure in adult life (Fig. 1). 
First of all it concerns the amount of protein intake 
during pregnancy. It was shown that the offspring of 
mothers who had experienced a limited amount of 
protein intake during pregnancy were characterized 
by a lower number of nephrons and higher mean 
arterial blood pressure [17, 18]. In various studies, 
both experimental and clinical, it has been estimated 
that the reduction of the number of functioning 
nephron due to reduced protein intake ranged from 
11% to 30% [19]. In experimental studies on rats, 
Burdge et al. demonstrated that the protein intake 
restriction during pregnancy reduced DNA methy-
lation of PPAR alpha gene in the offspring [20]. In 
addition, such a maternal diet reduced the expression 
of AT1 and AT2 receptors in the offspring [21]. An-
other factor contributing to the decrease of the neph-
rons number in offspring is a vitamin A deficiency 
during pregnancy [22]. In humans it was shown 
that there was reduction of the kidney volume in 
the offspring of mothers who had decreased plasma 
concentration of vitamin A during pregnancy [23]. 
Results of experimental studies suggest the negative 
effects of iron and zinc deficiencies in mothers on 
the number of nephrons in offspring [24–27]. The 
number of foetal nephrons is also affected by the 
Figure 1. Pathomechanism of foetal programming in the pathogenesis 
of arterial hypertension
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sodium intake during pregnancy. This relationship 
is however complex [28]. Both too high and too 
low sodium intake lead to the nephrons number re-
duction in offspring. High sodium diet reduced the 
renin-angiotensin system activity. Intact foetal kid-
ney RAA activity is necessary for the proper kidney 
growth. On the other hand, too low sodium intake 
decreases the blood flow through the placenta. Both 
of these mechanisms seems to affect adversely the 
number of nephrons in the kidneys of the foetus. It 
has been shown in the experimental studies that the 
consumption of ethanol during pregnancy reduces 
the number of nephrons in the foetus and results in 
blood pressure increase during adult life [29, 30]. 
Also cigarette smoking adversely affects the develop-
ment of foetal kidneys by reducing the number of 
podocytes, as shown by experimental study in rats 
[31]. In observational studies in humans systolic 
blood pressure was increased in those whose moth-
ers smoked cigarettes during pregnancy [32]. Other 
studies have confirmed an increase of blood pressure 
both in childhood and in adult life in the offspring 
of mothers who smoke during pregnancy [33, 34]. In 
children of mothers smoking during pregnancy, a re-
duction of renal volume in ultrasound examination 
was also observed [35].
Drugs affecting foetal kidney 
development
The number of nephrons in the foetus is also af-
fected by several drugs used by pregnant female. 
In many experimental and clinical studies the neg-
ative effects of glucocorticoids on number of neph-
rons in the foetus and blood pressure in offspring 
have been shown [36–39]. 
Doyle et al. in a cohort study of 210 14-year-old 
children compared individuals exposed to antenatal 
corticosteroids with those who did not have such 
an exposition. Children exposed to corticosteroids 
during foetal period had higher systolic and diastolic 
blood pressure [37]. There is expression of 11b-hy-
droxysteroid dehydrogenase type 2 in placenta during 
pregnancy, which protects the foetus against an ex-
cessive amount of both endogenous (e.g. severe stress 
in the mother) or exogenous glucocorticoids [40]. In 
experimental studies on pregnant rats carbenoxol-
one, an 11BHSG2 inhibitor, was administered. This 
resulted in blood pressure increase in the offspring 
[41]. It was also shown that protein restriction in 
the diet reduced 11b-HSD2 activity [42]. Therefore 
malnutrition during pregnancy may result in the 
more intensive exposure of foetus on glucocorticoids.
Another drug influencing the development of the 
kidney in the foetus is calcineurin inhibitor, cyclo-
sporine A. Experimental study in rats has shown that 
administration of cyclosporine A during pregnancy 
reduces the number of glomeruli, increases glomeruli 
volume and increases blood pressure in the offspring 
[43]. Also, administration of amoxicillin and ampi-
cillin during pregnancy in rats contributed to the 
deterioration of kidney development in its foetuses 
[44]. Moreover Gilbert et al. in studies on guinea 
pigs have shown the negative effect of gentamycin 
exposition during pregnancy on foetal kidney devel-
opment [45]. The clinical relevance of these observa-
tions needs, however, further studies.
Mechanism of prenatal programming
It is known that the mechanisms involved in foe-
tal programming are epigenetic. Epigenetic chang-
es involve modification of gene expression without 
changing the genetic material. They consist of modi-
fying the DNA structure or function by DNA meth-
ylation, histones modification and micro RNA.
The most important of epigenetic changes are 
DNA methylation. Methylation modifies genes’ 
structure by attaching a methyl group to cytosine. 
These may change the gene expression. In the past 
few years, some studies have shown a relationship 
between exposure to nutrients during pregnancy and 
the change of foetus DNA methylation [46]. Hogg 
et al. observed increase in DNA methylation in pla-
centas of pregnant women with hypertension com-
pared with women with normal blood pressure [47]. 
There are some studies that have shown that factors 
that increase DNA methylation causes the develop-
ment of cardiovascular disease, including hyperten-
sion [48]. Experimental studies on rats have shown 
that increased folic acid intake during pregnancy 
enhanced methylation in glucocorticosteroid recep-
tor gene and results in an increase in blood pressure 
in susceptible offspring [49]. The mentioned above 
11b-HSD2 enzyme activation is regulated by histone 
methylation of its gene [50]. In experimental studies 
on mice it has been shown that the methylation of 
lysine residue 79 at histone H3 reduces 11b-HSD2 
gene expression [51]. An abnormal increase of meth-
ylation of 11b-HSD2 promotor seems to lead to 
hypertension. It has been shown that calcium defi-
ciency in pregnant rats leads to a reduction of meth-
ylation 11b-HSD1 gene and glucocorticosteroid 
receptor NR3C1 in the offspring [52]. It is known 
that increased plasma cortisol concentration leads to 
hypertension [53]. In addition, a low protein diet 
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during pregnancy causes hypomethylation of AT1b 
angiotensin receptor gene in the adrenal glands of 
the offspring [54].
Second mechanism of epigenetic regulation 
is a post-translational modification of histones 
(PTMs). It has been shown that histone acetylation 
plays a key role in the development of hypertension 
associated with glucocorticoids [55]. Furthermore, 
histone acetylation plays an important role in upreg-
ulating 11b-HSD2 activity in human placenta [56]. 
Glucocorticoids may program the foetus through 
epigenetic modifications to the development of hy-
pertension [57]. It has been shown that dexameth-
asone leads to a reduction of the interferon-gamma 
gene expression by histone deacetylation [58]. This 
leads to the development of hypertension in the 
offspring [59].
Third mechanism of epigenetic regulation may be 
a regulation based on micro RNA (miRNA). These 
small fragments of RNA inhibits the degradation 
of messenger RNA (mRNA) and translation. It has 
been shown both in vitro and in vivo that glucocorti-
costeroid receptor expression and activity is reduced 
by miR-124 and miR-18 [60]. Other studies have 
demonstrated that the other types of miRNA re-
duce glucocorticoid receptor expression in the adre-
nal glands in mice [61]. These mechanisms may be 
also involved in pathogenesis of hypertension in the 
offspring.
Summary
In summary, the factors affecting the development 
of foetal kidneys may also predispose to the develop-
ment of arterial hypertension in the adult life. For 
this reason, prevention against development of ar-
terial hypertension should start already during preg-
nancy. The most important elements of such a pro-
phylaxis should be balanced diet, healthy lifestyle, 
avoiding smoking cigarettes, alcohol consumption 
and drugs affecting the development of the foetal 
kidneys, such as corticosteroids and probably some 
immunosuppressive drugs or antibiotics.
References
1. Barker D.J., Osmond C. Infant mortality, childhood nutrition, 
and ischaemic heart disease in England and Wales. Lancet 1986; 
1: 1077–1081.
2. Barker D.J., Bagby S.P., Hanson M.A. Mechanisms of disease: in 
utero programming in the pathogenesis of hypertension. Nat. Clin. 
Pract. Nephrol. 2006; 2: 700–707.
3. Mu M., Wang S.F., Sheng J. et al. Birth weight and subsequent blood 
pressure: a meta-analysis. Arch. Cardiovasc. Dis. 2012; 105: 99–113.
4. Rettig R., Folberth C., Stauss H. et al. Role of the kidney in primary 
hypertension: a renal transplantation study in rats. Am. J. Physiol. 
1990; 258: 606–611.
5. Patschan O., Kuttler B., Heemann U. et al. Kidneys from normoten-
sive donors lower blood pressure in young transplanted spontaneously 
hypertensive rats. Am. J. Physiol. 1997; 273: 175–180.
6. Curtis J.J., Luke R.G., Dustan H.P. et al. Remission of essential 
hypertension after renal transplantation. N. Engl. J. Med. 1983; 
309: 1009–1015.
7. Puelles V.G., Hoy W.E., Hughson M.D. et al. Glomerular number 
and size variability and risk for kidney disease. Curr. Opin. Nephrol. 
Hypertens. 2011; 20: 7–15.
8. Keller G., Zimmer G., Mall G. et al. Nephron number in patients 
with primary hypertension. N. Engl. J. Med. 2003; 348: 101–108.
9. Hughson M.D., Douglas-Denton R., Bertram J.F., Hoy W.E. Hyper-
tension, glomerular number, and birth weight in African Americans 
and white subjects in the southeastern United States. Kidney Int. 
2006; 69: 671–678.
10. Quigley R. Developmental changes in renal function. Curr. Opin. 
Pediatr. 2012; 24: 184–190.
11. Mañalich R., Reyes L., Herrera M. et al. Relationship between weight 
at birth and the number and size of renal glomeruli in humans: a 
histomorphometric study. Kidney Int. 2000; 58: 770–773.
12. Hughson M., Farris A.B. 3rd, Douglas-Denton R. et al. Glomerular 
number and size in autopsy kidneys: the relationship to birth weight. 
Kidney Int. 2003; 63: 2113–2122.
13. Luyckx V.A., Bertram J.F., Brenner B.M. et al. Effect of fetal and child 
health on kidney development and long-term risk of hypertension 
and kidney disease. Lancet 2013; 382: 273–283.
14. Hoy W.E., Douglas-Denton R.N., Hughson M.D. et al. A stereolog-
ical study of glomerular number and volume: preliminary findings 
in a multiracial study of kidneys at autopsy. Kidney Int. Suppl. 
2003; 83: S31–37.
15. Keijzer-Veen M.G., Devos A.S., Meradji M. et al. Reduced renal 
length and volume 20 years after very preterm birth. Pediatr. Nephrol. 
2010; 25: 499–507.
16. Pruijm M., Ponte B., Ackermann D. et al. Heritability, determinants 
and reference values of renal length: a family-based population study. 
Eur. Radiol. 2013; 23: 2899–2905.
17. Woods L.L., Ingelfinger J.R., Nyengaard J.R., Rasch R. Maternal pro-
tein restriction suppresses the newborn renin-angiotensin system and 
programs adult hypertension in rats. Pediatr. Res. 2001; 49: 460–467.
18. Woods L.L., Weeks D.A., Rasch R. Programming of adult blood 
pressure by maternal protein restriction: role of nephrogenesis. 
Kidney Int. 2004; 65: 1339–1348.
19. Bagby S.P. Maternal nutrition, low nephron number, and hyper-
tension in later life: pathways of nutritional programming. J. Nutr. 
2007; 137: 1066–1072.
Table I. Environmental factors affecting the foetus causes decreasing of nephron number





High or too low sodium intake
Glucocorticoids
Cyclosporine A
Antibiotics (gentamicin, ampicillin, amoxicillin)
Ethanol intake
Cigarette smoking
arterial hypertension 2016, vol. 20, no. 4
232 www.ah.viamedica.pl
20. Burdge G.C., Slater-Jefferies J., Torrens C. et al. Dietary protein 
restriction of pregnant rats in the F0 generation induces altered 
methylation of hepatic gene promoters in the adult male offspring in 
the F1 and F2 generations. Br. J. Nutr. 2007; 97: 435–439.
21. Mesquita F.F., Gontijo J.A., Boer P.A. Maternal undernutrition and 
the offspring kidney: from fetal to adult life. Braz. J. Med. Biol. Res. 
2010; 43: 1010–1018.
22. Lelièvre-Pégorier M., Vilar J., Ferrier M.L. et al. Mild vitamin A 
deficiency leads to inborn nephron deficit in the rat. Kidney Int. 
1998; 54: 1455–1462.
23. Goodyer P., Kurpad A., Rekha S. et al. Effects of maternal vitamin 
A status on kidney development: a pilot study. Pediatr. Nephrol. 
2007; 22: 209–214.
24. Lisle S.J., Lewis R.M., Petry C.J. et al. Effect of maternal iron 
restriction during pregnancy on renal morphology in the adult rat 
offspring. Br. J. Nutr. 2003; 90: 33–39.
25. Swali A., McMullen S., Hayes H. et al. Processes underlying the nu-
tritional programming of embryonic development by iron deficiency 
in the rat. PLoS One 2012; 7: 48133.
26. Tomat A.L., Inserra F., Veiras L. et al. Moderate zinc restriction 
during fetal and postnatal growth of rats: effects on adult arterial 
blood pressure and kidney. Am. J. Physiol. Regul. Integr. Comp. 
Physiol. 2008; 295: 543–549.
27. Tomat A.L., Veiras L.C., Aguirre S. et al. Mild zinc deficiency in 
male and female rats: early postnatal alterations in renal nitric oxide 
system and morphology. Nutrition 2013; 29: 568–573.
28. Koleganova N., Piecha G., Ritz E. et al. Both high and low maternal 
salt intake in pregnancy alter kidney development in the offspring. 
Am. J. Physiol. Renal. Physiol. 2011; 301: 344–354.
29. Gray S.P., Denton K.M., Cullen-McEwen L. et al. Prenatal exposure 
to alcohol reduces nephron number and raises blood pressure in 
progeny. J. Am. Soc. Nephrol. 2010; 21: 1891–1902.
30. Gray S.P., Cullen-McEwen L.A., Bertram J.F., Moritz K.M. Mech-
anism of alcohol-induced impairment in renal development: Could 
it be reduced by retinoic acid? Clin. Exp. Pharmacol. Physiol. 2012; 
39: 807–813.
31. Zarzecki M., Adamczak M., Wystrychowski A. et al. Exposure of 
pregnant rats to cigarette-smoke condensate causes glomerular abnor-
malities in offspring. Kidney Blood Press. Res. 2012; 36: 162–171.
32. Geerts C.C., Grobbee D.E., van der Ent C.K. et al. Tobacco smoke 
exposure of pregnant mothers and blood pressure in their newborns: 
results from the wheezing illnesses study Leidsche Rijn birth cohort. 
Hypertension 2007; 50: 572–578.
33. Lawlor D.A., Najman J.M., Sterne J. et al. Associations of parental, 
birth, and early life characteristics with systolic blood pressure at 5 
years of age: findings from the Mater-University study of pregnancy 
and its outcomes. Circulation 2004; 110: 2417–2423.
34. Högberg L., Cnattingius S., Lundholm C. et al. Effects of maternal 
smoking during pregnancy on offspring blood pressure in late ado-
lescence. J. Hypertens. 2012; 30: 693–699.
35. Taal H.R., Geelhoed J.J., Steegers E.A. et al. Maternal smoking dur-
ing pregnancy and kidney volume in the offspring: the Generation 
R Study. Pediatr. Nephrol. 2011; 26: 1275–1283.
36. Ortiz L.A., Quan A., Zarzar F. et al. Prenatal dexamethasone pro-
grams hypertension and renal injury in the rat. Hypertension 2003; 
41: 328–334.
37. Doyle L.W., Ford G.W., Davis N.M., Callanan C. Antenatal corti-
costeroid therapy and blood pressure at 14 years of age in preterm 
children. Clin. Sci. (Lond.) 2000; 98: 137–142.
38. Wintour E.M., Moritz K.M., Johnson K. et al. Reduced nephron 
number in adult sheep, hypertensive as a result of prenatal glucocor-
ticoid treatment. J. Physiol. 2003; 549: 929–935.
39. Celsi G., Kistner A., Aizman R. et al. Prenatal dexamethasone causes 
oligonephronia, sodium retention, and higher blood pressure in the 
offspring. Pediatr. Res. 1998; 44: 317–322.
40. Seckl J.R., Holmes M.C. Mechanisms of disease: glucocorticoids, 
their placental metabolism and fetal ‘programming’ of adult patho-
physiology. Nat. Clin. Pract. Endocrinol. Metab. 2007; 3: 479–488.
41. Seckl J.R., Cleasby M., Nyirenda M.J. Glucocorticoids, 11beta-hy-
droxysteroid dehydrogenase, and fetal programming. Kidney Int. 
2000; 57: 1412–1417.
42. Langley-Evans S.C., Phillips G.J., Benediktsson R. et al. Protein in-
take in pregnancy, placental glucocorticoid metabolism and the pro-
gramming of hypertension in the rat. Placenta 1996; 17: 169–172.
43. Slabiak-Blaz N., Adamczak M., Gut N. et al. Administration of 
cyclosporine A in pregnant rats — the effect on blood pressure and 
on the glomerular number in their offspring. Kidney Blood Press. 
Res. 2015; 40: 413–423.
44. Nathanson S., Moreau E., Merlet-Benichou C., Gilbert T. In utero 
and in vitro exposure to beta-lactams impair kidney development in 
the rat. J. Am. Soc. Nephrol. 2000; 11: 874–884.
45. Gilbert T., Lelievre-Pegorier M., Merlet-Benichou C. Immediate 
and long-term renal effects of fetal exposure to gentamicin. Pediatr. 
Nephrol. 1990; 4: 445–450.
46. Anwar M.A., Saleh A.I., Al Olabi R. et al. Glucocorticoid-induced 
fetal origins of adult hypertension: Association with epigenetic events. 
Vascul. Pharmacol. 2016: 1537–1891.
47. Hogg K., Blair J.D., McFadden D.E. et al. Early onset pre-eclampsia 
is associated with altered DNA methylation of cortisol signaling and 
steroidogenic genes in the placenta. PLoS One. 2013; 8: e62969.
48. Palatini P., Casiglia E., Pauletto P. et al. Relationship of tachycardia with 
high blood pressure and metabolic abnormalities: a study with mixture 
analysis in three populations. Hypertension 1997 ; 30: 1267–1273.
49. Burdge G.C., Lillycrop K.A., Phillips E.S. et al. Folic acid supple-
mentation during the juvenile-pubertal period in rats modifies the 
phenotype and epigenotype induced by prenatal nutrition. J. Nutr. 
2009; 139: 1054–1060.
50. Togher K.L., Togher K.L., O’Keeffe M.M. et al. Epigenetic regulation 
of the placental HSD11B2 barrier and its role as a critical regulator 
of fetal development. Epigenetics 2014; 9: 816–822.
51. Millis R.M. Epigenetics and hypertension. Curr. Hypertens. Rep. 
2011; 13: 21–28.
52. Takaya J., Iharada A., Okihana H., Kaneko K. A calcium-deficient 
diet in pregnant, nursing rats induces hypomethylation of specific 
cytosines in the 11b-hydroxysteroid dehydrogenase-1 promoter in 
pup liver. Nutr. Res. 2013; 33: 961–970.
53. Whitworth J.A., Williamson P.M., Mangos G., Kelly J.J. Cardio-
vascular consequences of cortisol excess. Vasc. Health Risk Manag. 
2005; 1: 291–299.
54. Bogdarina I., Welham S., King P.J. et al. Epigenetic modification of 
the renin-angiotensin system in the fetal programming of hyperten-
sion. Circ. Res. 2007; 100: 520–526.
55. Stratton M.S., McKinsey T.A. Acetyl-lysine erasers and readers in the 
control of pulmonary hypertension and right ventricular hypertrophy. 
Biochem. Cell Biol. 2015; 93: 149–157.
56. Li J., Wang W., Liu C. et al. Critical role of histone acetylation by 
p300 in human placental 11b-HSD2 expression. J. Clin. Endocrinol. 
Metab. 2013; 98: 1189–1197.
57. Thompson L.P., Al-Hasan Y. Impact of oxidative stress in fetal pro-
gramming. J. Pregnancy 2012; 2012: 582748.
58. Krukowski K., Eddy J., Kosik K.L. et al. Glucocorticoid dysregulation 
of natural killer cell function through epigenetic modification. Brain 
Behav. Immun. 2011; 25: 239–249.
59. Ishimitsu T., Uehara Y., Numabe A. et al. Interferon gamma attenu-
ates hypertensive renal injury in salt-sensitive Dahl rats. Hypertension 
1992; 19: 804–808.
60. Vreugdenhil E., Verissimo C.S., Mariman R. et al. MicroRNA 18 
and 124a down-regulate the glucocorticoid receptor: implications 
for glucocorticoid responsiveness in the brain. Endocrinology 2009; 
150: 2220–2228.
61. Riester A., Issler O., Spyroglou A. et al. ACTH-dependent regulation 
of microRNA as endogenous modulators of glucocorticoid receptor 
expression in the adrenal gland. Endocrinology 2012; 153: 212–222.
62. Lisle S.J., Lewis R.M., Petry C.J et al. Effect of maternal iron restric-
tion during pregnancy on renal morphology in the adult rat offspring. 
Br. J. Nutr. 2003; 90: 33–39.
